New hive drug trial halted midway
Symptom relief
Terminated
This study tested an experimental drug called EP262 for people with chronic spontaneous urticaria (long-lasting hives with no clear cause). It included 113 adults who still had symptoms despite taking standard antihistamines. The goal was to see if EP262 could reduce itching and …
Phase: PHASE2 • Sponsor: Escient Pharmaceuticals, Inc • Aim: Symptom relief
Last updated May 26, 2026 11:59 UTC